4-87845221-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_020203.6(MEPE):c.353C>T(p.Pro118Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000155 in 1,613,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020203.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MEPE | NM_020203.6 | c.353C>T | p.Pro118Leu | missense_variant | 4/4 | ENST00000361056.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MEPE | ENST00000361056.4 | c.353C>T | p.Pro118Leu | missense_variant | 4/4 | 1 | NM_020203.6 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.000164 AC: 25AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000303 AC: 76AN: 251030Hom.: 0 AF XY: 0.000287 AC XY: 39AN XY: 135694
GnomAD4 exome AF: 0.000154 AC: 225AN: 1461694Hom.: 0 Cov.: 32 AF XY: 0.000150 AC XY: 109AN XY: 727146
GnomAD4 genome ? AF: 0.000164 AC: 25AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.353C>T (p.P118L) alteration is located in exon 4 (coding exon 3) of the MEPE gene. This alteration results from a C to T substitution at nucleotide position 353, causing the proline (P) at amino acid position 118 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
MEPE-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 21, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at